Related Experiment Video
Updated: Nov 26, 2025

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
Development of a new comorbidity index for adults with cerebral palsy and comparative assessment with common
Daniel G Whitney1,2, Neil S Kamdar2,3,4,5
1Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, USA.
Insights
A new Whitney Comorbidity Index (WCI) for adults with cerebral palsy (CP) better predicts mortality than existing measures. The WCI includes relevant comorbidities for improved accuracy in CP patient outcomes.
Area of Science:
- Medical research
- Public health
- Clinical informatics
Background:
- Existing comorbidity indices like the Charlson Comorbidity Index (CCI) and Elixhauser Comorbidity Index (ECI) do not adequately capture relevant comorbidities for adults with cerebral palsy (CP).
- Accurate comorbidity assessment is crucial for predicting mortality and managing healthcare for individuals with CP.
Purpose of the Study:
- To develop and validate a new comorbidity index, the Whitney Comorbidity Index (WCI), specifically for adults with cerebral palsy (CP).
- To assess if the WCI demonstrates superior performance in predicting mortality compared to the CCI and ECI in this population.
Main Methods:
- A retrospective cohort study utilized data from the Optum Clinformatics Data Mart, including 3022 adults with CP (1511 females, 1511 males).
- Diagnosis codes identified comorbidities. The WCI was developed using Cox regression and competing risk analysis, incorporating comorbidities from CCI and ECI plus additional relevant ones.
- Model fit and discrimination (C-statistic) were evaluated for unweighted (WCIunw) and weighted (WCIw) versions of the WCI, CCI, and ECI.
Main Results:
- The WCI incorporated 27 comorbidities, including seven new ones not present in the CCI or ECI.
- Both WCIunw and WCIw demonstrated superior model fit and discrimination for 1- and 2-year mortality compared to CCI and ECI.
- The WCI indices were strong predictors of mortality, with C-statistics ranging from 0.81 to 0.88.
Conclusions:
- The Whitney Comorbidity Index (WCI) is a novel and effective tool for assessing comorbidity burden in adults with cerebral palsy.
- The WCI offers improved prediction of mortality for adults with CP, outperforming established indices like CCI and ECI.
- This index, developed through a combination of clinical insight and data analysis, can aid in better patient management and outcome prediction for the CP population.
Aim:
To develop a new comorbidity index for adults with cerebral palsy (CP), the Whitney Comorbidity Index (WCI), which includes relevant comorbidities for this population and better predicts mortality than the Charlson Comorbidity Index (CCI) and Elixhauser Comorbidity Index (ECI).
Method:
Data from the Optum Clinformatics Data Mart was used for this retrospective cohort study. Diagnosis codes were used to identify adults aged 18 years or older with CP (n=1511 females, n=1511 males; mean [SD; range] age=48y [19y 2mo; 18-89y]) and all comorbidities in the year 2014. The WCI was developed based on the comorbidities of the CCI and ECI and other relevant comorbidities associated with 2-year mortality using Cox regression and competing risk analysis. The WCI was examined as unweighted (WCIunw ) and weighted (WCIw ). The model fit and discrimination (C-statistic) of each index was assessed using Cox regression.
Results:
Twenty-seven comorbidities were included in the WCI; seven new comorbidities that were not part of the CCI or ECI were added. The WCIunw and WCIw showed a better model fit and discrimination for 1- and 2-year mortality compared to the CCI and ECI. The WCIunw and WCIw were strong predictors for 1- and 2-year mortality (C-statistic [95% confidence interval] ranging from 0.81 [0.76-0.85] to 0.88 [0.82-0.94]).
Interpretation:
The new WCI, designed to include clinically relevant comorbidities, provides a better model fit and discrimination of mortality for adults with CP.
What This Paper Adds:
Common comorbidity indices exclude relevant comorbidities for adults with cerebral palsy (CP). A new comorbidity index for adults with CP was created by harmonizing clinical theory and data-driven methods. The Whitney Comorbidity Index better predicted 1- and 2-year mortality than other commonly used comorbidity indices.
Related Concept Videos
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Intellectual Disability
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

